Crispr | CRISPR, crispr genome editing system

Home » Archive by category "crispr"

Crispr Could Eradicate Acne

For many people, high school is marked by socially recognized rites of passage such as proms, awkward first dates, and the stress of dramatic hormonal changes. For many, acne in particular is a major source of discomfort, self-consciousness, and even embarrassment. But now, acne treatment could be entering a new phase through synthetic biology innovation. It’s estimated that 85% of teens and young adults globally suffer from acne flare-ups. There are a number of myths as to what causes this condition. Chocolate, greasy food, cosmetics, and even skin hygiene are often blamed for acne outbreaks. The truth is that acne is caused by dead skin cells and excess protective skin oil (sebum) clogging the hair follicles. Excess sebum is typically...
Read More..

CRISPR Investment: A Great Opportunity And Perspective For All Developers And Investors

Why invest in CRISPR? The rapid growth of the bioscience industry has presented savvy investors with many opportunities to make a lot of money in recent years, and that should only continue as new technologies with the power to reshape that industry continue to be developed. One of the most exciting and revolutionary new technologies on the horizon with a great investment perspective is the CRISPR system, that promises tremendous breakthroughs in treating and preventing genetically-driven diseases, such as a nice return for CRISPR investors. In fact, searching out stocks or other assets related to CRISPR to invest in could prove to be one of the smartest decisions you could make with your portfolio right now. The CRISPR gene editing system has...
Read More..

UK researchers plan to genetically modify human embryos

crispr image15
Researchers at the Francis Crick Institute have applied to Britain’s regulators to use new “genome editing” techniques on human embryos, according to a statement released Friday by the institute. Genome editing techniques on human embryos are still seen as “forbidden fruit” in many countries. Once the the Human Fertilization and Embryology Authority (HFEA) approves the application, the research project will focus on understanding the genes human embryos need to develop successfully, and any donated embryos will be used for research purposes only, according to the statement. Editing the genomes of human embryos for a therapeutic use – for example, to eradicate a genetic disease – is illegal in Britain, but research work is possible under license from the HFEA. The...
Read More..

Using CRISPR gene editing to shut down mosquitoes as disease carriers

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.  Mosquitoes are a key contributor to the spread of potentially deadly diseases such as dengue and malaria, as they harbor parasites and viruses that are spread when mosquitoes bite humans and animals. Now, researchers at the University of Missouri have found an effective way to edit the genes of mosquitoes.  Shengzhang Dong, postdoctoral fellow in the Department of Veterinary Pathobiology of the MU College of Veterinary Medicine, says this new technique opens the door for future research into genetically modifying mosquitoes so they cannot carry and transmit viruses and parasites that are harmful to humans. “By successfully editing specific genes in the Aedes aegytpi,...
Read More..

Batu Biologics Utilizes CRISPR to Modify T Cells

crispr image2
Batu Biologics, an immuno-oncology company, has recently filed intellectual property and initiated discovery research on a new method of augmenting an anti-tumor immune response through ex vivo manipulation of the patient’s T cells. “Batu Biologics plans to utilize this groundbreaking technology to support our efforts in harnessing and unleashing the power of the patient’s immune system. This is another step in the direction of breaking immunological tolerance to cancer.” The inhibition of popular “immune checkpoints” has proven to be an effective way to potentiate T cell responses as a treatment for multiple solid tumor indications. Blocking these immune checkpoints in vivo has shown significant effectiveness in open label placebo controlled clinical trials, resulting in the FDA approval of Bristol-Myers Squibb’s...
Read More..

Crispr: A New Cell-Editing Technique Found to be 72% Effective in Defeating HIV

crispr image14
A group of scientist recently claim that they are one-step closer into finding a cure for HIV and AIDS. HIV is hard to cure mainly because of its ability to hide in the body and pretend to be a good cell. However a new approach has been found with could edit a cell infected by HIV. The new method has been found to be 72% effective. In their recent tests, they found that their technique was able to remove up to 72% of the HIV cell from the infected. They way they do it, they customize the defence system of a bacteria and train it’s scissor like machine. They call it ‘Crispr’. Crispr accurately changes the target parts’ genetic code....
Read More..

Berkeley Scientists Cut Up Genomes to Create Guide RNA Libraries for CRISPR Screens

Биохимические исследования
Scientists from the University of California, Berkeley have developed a new way to efficiently create genome-wide libraries of guide RNAs (gRNAs) for CRISPR-based studies. The libraries can be used both for gene editing knock-out screens as well fluorescent tagging of chromosomes. Led by Andrew Lane and Rebecca Heald, the scientists developed a method to create gRNAs from the genome of an organism itself, rather than making them synthetically. “We reasoned that potentially any DNA sequence could be enzymatically processed into a library of sgRNAs and used to tile along a chromosomal region,” the authors wrote in the study published today online inDevelopmental Cell. The gRNA is what makes CRISPR/Cas9 such a flexible and powerful technology, able to target almost any...
Read More..

A gene-sequence swap using CRISPR to cure hemophilia

crispr image7
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases Sufferers of hemophilia live in a perpetual state of stress and anxiety: their joints wear down prematurely and they have bleeding episodes that feel like they will never end.  Their bodies lack the ability to make the clotting factor responsible for the coagulation of blood so any cut or bruise can turn into an emergency without immediate treatment. Hemophilia A occurs in about 1 in 5,000 male births and almost half of severe cases are caused by identified “chromosomal inversions”.  In a chromosomal inversion, the order of the base pairs on the chromosome are reversed so the gene doesn’t express properly and...
Read More..